Hematopoietic support with moderately myelosuppressive chemotherapy regimens: a nursing perspective.

Clinical journal of oncology nursing

Volumn 10, Issue 3, 2006, Pages 383-388

  Moore, Kelley ^a   Crom, Debbie ^a  

^a Supportive Oncology Services Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DOCETAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TAXOID;

BREAST TUMOR; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DRUG COMBINATION; ECONOMICS; FEMALE; HUMAN; MIDDLE AGED; NEUTROPENIA; NURSING; REVIEW;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CLINICAL TRIALS; COST-BENEFIT ANALYSIS; DRUG THERAPY, COMBINATION; FEMALE; FILGRASTIM; HUMANS; MIDDLE AGED; NEUTROPENIA; TAXOIDS;

EID: 33746463660     PISSN: 10921095     EISSN: None     Source Type: Journal    
DOI: 10.1188/06.CJON.383-388     Document Type: Review

References (50)